Diverse roles of insulin-like growth factors in pediatric solid tumors
- PMID: 8054516
Diverse roles of insulin-like growth factors in pediatric solid tumors
Abstract
Insulin-like growth factors are abnormally expressed in some pediatric solid tumors. In addition, tumors that do not show significant alterations in pattern of expression are responsive to and may be dependent upon insulin-like growth factors for proliferation. These can be produced by the tumor cells (autocrine), surrounding stromal cells (paracrine), or at a distance (endocrine). Insulin-like growth factor-II plays a role in Wilm's tumor, neuroblastoma, and rhabdomyosarcoma, either as a proliferation factor, a motility factor, or both. Insulin-like growth factor-I may regulate osteosarcoma and the Ewing's family of tumors (primitive neuroectodermal tumors). Understanding the biology of these growth factors and their receptors can lead to new therapeutic approaches.
Similar articles
-
Insulin-like growth factors: polypeptides with diverse physiological roles.Mead Johnson Symp Perinat Dev Med. 1988;(32):12-20. Mead Johnson Symp Perinat Dev Med. 1988. PMID: 2485435 Review. No abstract available.
-
The expression of mRNA for insulin-like growth factors and their receptor in giant cell tumors of human bone.Clin Orthop Relat Res. 1996 Jan;(322):224-31. Clin Orthop Relat Res. 1996. PMID: 8542699
-
[Insulin-like growth factors (IGF) and their binding proteins (IGFBP). Physiological and pathological regulation].Journ Annu Diabetol Hotel Dieu. 1995:29-38. Journ Annu Diabetol Hotel Dieu. 1995. PMID: 7541484 Review. French. No abstract available.
-
An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.Biochem Pharmacol. 2004 Sep 15;68(6):1003-15. doi: 10.1016/j.bcp.2004.05.029. Biochem Pharmacol. 2004. PMID: 15313394 Review.
-
The role of the IGF axis in hepatocarcinogenesis.Horm Metab Res. 2003 Nov-Dec;35(11-12):685-93. doi: 10.1055/s-2004-814151. Horm Metab Res. 2003. PMID: 14710347 Review.
Cited by
-
The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma.Cancer Res. 2009 Oct 1;69(19):7662-71. doi: 10.1158/0008-5472.CAN-09-1693. Epub 2009 Sep 29. Cancer Res. 2009. PMID: 19789339 Free PMC article.
-
An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential.Clin Exp Metastasis. 2000;18(3):261-71. doi: 10.1023/a:1006767007547. Clin Exp Metastasis. 2000. PMID: 11315100
-
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program.Pediatr Blood Cancer. 2011 Apr;56(4):595-603. doi: 10.1002/pbc.22741. Epub 2010 Dec 22. Pediatr Blood Cancer. 2011. PMID: 21298745 Free PMC article.
-
Physeal bystander effects in rhabdomyosarcoma radiotherapy: experiments in a new xenograft model.Sarcoma. 2011;2011:815190. doi: 10.1155/2011/815190. Epub 2011 Apr 17. Sarcoma. 2011. PMID: 21559211 Free PMC article.
-
Progress of fundamental research in Wilms' tumor.Urol Res. 1997;25(4):223-30. doi: 10.1007/BF00942090. Urol Res. 1997. PMID: 9286029 Review.